| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-06 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-06 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-06 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |